| Author (Person) | (et al.), |
|---|---|
| Author (Corporate) | European Medicines Agency |
| Publisher | EC |
| Publication Date | 05/11/2009 |
| Content Type | Overview |
|
The European Medicines Agency (EMEA), the European Centre for Disease Prevention and Control (ECDC) and the Heads of Medicines Agencies, in October 2009, adopted a strategy to further strengthen the coordination of benefit-risk monitoring for influenza A/H1N1 vaccines. The strategy was published on the EMEA website on 5 November 2009. |
|
| Source Link | Link to Main Source http://www.emea.europa.eu/pdfs/human/pandemicinfluenza/european_strategy.pdf |
| Related Links |
|
| Subject Categories | Health |
| Countries / Regions | Europe |
